Recursion Pharmaceuticals, Inc. (RXRX)
NGS · Common · CUSIP 75629V104
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for RXRX and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
75629V104
Market Cap
Large Cap
IPO
4/16/2021 · $18.00/share
Business: Recursion Pharmaceuticals, Inc. a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.

Company Contact

CEO
Chris Gibson
CFO
Michael Secora
Headquarters
41 S Rio Grande Street, Salt Lake City, UT 84101
Phone
385-269-0203
Investor Relations
Elyse Freeman · InvestorRelations@Recursion.com
SEC EDGAR Filings
View filings »